Cell-free DNA from cerebrospinal fluid can be used to detect the EGFR mutation status of lung adenocarcinoma patients with central nervous system metastasis

BACKGROUND: EGFR tyrosine kinase inhibitors (TKIs) have revolutionized the therapeutic approach for EGFR mutated patients. However, acquired resistance to EGFR-TKI therapy is unavoidable. Repeat biopsy cannot be used, and peripheral blood detection shows a low positive rate in cases of brain-only di...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yang, Yang, Sen, Zhao, Jiuzhou, He, Zhen, Ma, Jie, Guo, Yongjun, Wang, Wei, Yoshizawa, Akihiko, Prelaj, Arsela, Tiseo, Marcello, Normanno, Nicola, Van Schil, Paul E., Wang, Qiming, Yang, Xiaopeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947414/
https://www.ncbi.nlm.nih.gov/pubmed/33718032
http://dx.doi.org/10.21037/tlcr-21-62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947414/
https://www.ncbi.nlm.nih.gov/pubmed/33718032
http://dx.doi.org/10.21037/tlcr-21-62

Ejemplares similares